Introduction
The TRC8/RNF139 gene was identified in a unique family with the constitutional translocation, t(3;8)(3p14.2;q24.1), and hereditary renal and thyroid cancer (Cohen et al., 1979; Li et al., 1993; Gemmill et al., 1998) . TRC8 encodes an endoplasmic reticulum (ER) membrane-associated E3 ubiquitin (Ub) ligase disrupted by the translocation (Gemmill et al., 2002) . The targeting subunit of a second E3 ligase, encoded by the von Hippel-Lindau gene (VHL), is defective in most sporadic clear-cell renal cell carcinomas (ccRCC) (Kaelin, 2005) . The best-known targets for the VHL E3 ligase are the hypoxia-inducible transcription (HIF) factors, HIF-1 and -2a . The HIF system represents a major pathway for sensing oxygen levels and is directly linked to kidney tumorigenesis.
A novel oxygen-sensing mechanism involving lipid homeostasis was recently described in fission yeast (Hughes et al., 2005; Todd et al., 2006) . The sterol regulatory element binding protein (SREBP) homolog in Schizosaccharomyces pombe, Sre1, is activated by oxygen limitation while mutations in Sre1 inhibit cell growth under severe hypoxia (Hughes et al., 2005) . In mammalian cells, the SREBP transcription factors are responsible for coordinately inducing cholesterol and fatty acid biosynthetic enzymes, such as 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) (Horton et al., 2003; Goldstein et al., 2006) . Interestingly, ccRCCs contain abundant lipid inclusions composed of newly synthesized cholesterol esters and other neutral lipids (Clayman et al., 1986; Gebhard et al., 1987) , suggesting that deregulation of lipid homeostasis is characteristic for these tumors. Overexpressed SREBPs have been found in a variety of tumor types, including prostate (Ettinger et al., 2004) , breast (Martel et al., 2006) and glioblastoma (Ma et al., 2005) , and we have identified similar changes in ccRCCs (Lee et al., submitted) .
Only 60-70% of ccRCCs have direct defects in the VHL pathway and searches for mutations in other components of the VHL complex have proven negative (Clifford et al., 2001) . VHL loss alone appears insufficient for tumor development, suggesting that alterations in additional genes and/or regulatory pathways are necessary (Mandriota et al., 2002) . One candidate is TRC8 (Gemmill et al., 1998 (Gemmill et al., , 2002 (Gemmill et al., , 2005 , a 60 kDa ER protein with 10 predicted transmembrane segments and a sterol-sensing domain (Gemmill et al., 1998) , similar to those found in SCAP and HMGCR that confer sterol-sensitivity to the SREBP/lipid homeostatic pathway (Goldstein et al., 2006) . We have recently discovered that TRC8 stability is sterol-regulated (Lee et al., submitted). TRC8 also contains a RING-H2 domain in the C-terminus that catalyses in vitro ubiquitylation reactions (Lorick et al., 1999) . In Drosophila, DTrc8 is a potent growth suppressor and appears to function in conjunction with, or parallel to, DVhl (Gemmill et al., 2002 ). Here we demonstrate that TRC8 is a potent growth suppressor in mammalian cells, inducing G2/M arrest, decreased DNA synthesis and increased apoptosis. These in vitro effects, along with in vivo inhibition of tumorigenicity, are dependent upon the Ub ligase activity of the RING domain. TRC8 inhibits the expression of SREBP-regulated genes and ectopic expression of activated nuclear SREBP (nSREBP) partially restores growth to TRC8-inhibited cells. Our results suggest that TRC8 is a tumor suppressor implicated in a novel regulatory relationship linking the cholesterol/lipid biosynthetic pathway with cellular growth control.
Results

TRC8 inhibits proliferation of transformed kidney cells
Adenovirus infection of three ccRCC cell lines (SKRC-02, -09 and -17) was used to assess short-term effects of ectopic TRC8 expression (Figure 1a ). Co-expression of enhanced green fluorescent protein (EGFP) indicated transfection efficiency. Ad-TRC8 infection (multiplicity of infection (MOI) of 50, >90% EGFP positive) resulted in a five-fold reduction in cell proliferation after 48 h compared to cells infected with Ad-EGFP alone (Figure 1b) . Flow cytometry (SKRC-09 is shown in Figure 1c ) revealed a large increase in the sub-G1 apoptotic fraction in Ad-TRC8-infected cells compared to controls (Figure 1d) . These results support a tumorsuppressive function for TRC8 through inhibition of cell proliferation and induction of cell death.
To investigate these effects further, we utilized human embryonic kidney (HEK293) FlpIn TRex cells (293FI) in which TRC8 was placed under the control of a tetracycline-inducible promoter (Figure 2a) . Consistent with the adenovirus results, TRC8 suppressed the proliferation of 293FI cells compared to doxycycline (dox)-treated control cells (Figure 2b ). Flow cytometry demonstrated that TRC8 induced apoptosis and increased cell populations with 4N DNA content, consistent with G2/M arrest ( Figure 2c ). Bromodeoxyuridine (BrdU) incorporation, indicative of DNA synthesis, was suppressed by TRC8 ( Figure 2d ). These data indicate that in 293FI cells, TRC8 blocks proliferation by inhibiting DNA synthesis, increasing apoptosis and inducing cell-cycle arrest. 
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Mutation of the TRC8 RING-H2 domain abrogates Ub ligase activity
The C-terminus of TRC8 contains a RING-H2 domain (Gemmill et al., 1998) (Figure 3a ) competent for E3 Ub ligase activity (Lorick et al., 1999) . RING domains utilize Cys and His residues to coordinate two Zn 2 þ ions in a cross-braced configuration, creating a binding site for Ub-conjugating enzymes (E2s) (Zheng et al., 2000) . To evaluate the role of this domain for TRC8 function, we generated a series of alanine or serine substitution mutations in highly conserved amino acids and established their ubiquitylation activity in vitro. RING mutations were created in glutathione S-transferase (GST)-TRC8 fusion proteins encompassing amino acids 504-664. These mutations were chosen to either abrogate Zn 2 þ coordination sites, and thus disrupt RING folding, or to interfere with specific amino-acid motifs predicted to form an E2 binding site (Katoh et al., 2003) . Purified GST fusion proteins ( Figure 3c ) were assayed in reactions containing 32 P-labelled Ub, E1, ATP and Ube2d2 (formerly UbcH5b). Reaction products were analysed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography ( Figure 3b ). Wild-type GST-TRC8 generated prominent ubiquitylation products containing Ub multimers up to 3 and small amounts of higher molecular weight adducts (lane 2). The positive control GST-AO7 (lane 7), a RING domain-containing protein with well-defined Ub ligase activity, yielded abundant higher molecular weight products (Lorick et al., 1999) . In contrast, mutation of the Zn 2 þ -coordinating Cys residues in the CAIC and CPMC mutations resulted in nearly total ablation of ubiquitylation activity (lanes 3 and 6). Thus, as expected, direct disruption of the Zn 2 þ coordinating sites eliminated ubiquitylation activity for the TRC8 RING domain. The remaining mutations affected amino acids outside the Zn 2 þ binding sites and showed differential effects on ubiquitylation. LRK (lane 5) lost all activity while SAR (lane 4) retained about 30% of wild-type activity.
Growth suppression mediated by TRC8 is RING dependent We subsequently tested these mutations for growth effects in 293FI cells. Stable transfectants containing tetracyclineinducible RING mutants, including a deletion of the entire RING (DRH2), or the related RING protein, gp78, were generated and verified (Figure 4a -c). Viable cell counts were used to compare growth over 3 days between doxinduced control cells, and cells expressing TRC8 wt , TRC8
DRH2 and TRC8 CAIC ( Figure 4d ). While TRC8 wt -expressing cells failed to proliferate, as expected, expression of the CAIC mutation or DRH2 RING deletion yielded proliferation rates indistinguishable from control cells. Comparisons among all the RING mutants ( Figure 4e and Table 1) showed that the SAR mutation retained most of the growth inhibitory activity of wild type, whereas CAIC, LRK and CPMC grew almost as well as uninduced cells. These RING mutations thus lost nearly all growth inhibitory activity associated with wild-type TRC8. Expression of gp78, an ER-associated degradation (ERAD)-associated RING protein (Fang et al., 2001) related to TRC8 (40% similar over 200 amino acids) resulted in no detectable growth inhibition, showing that this effect is specific for TRC8. Flow cytometry confirmed that all mutants in Zn 2 þ coordination sites (asterisks) were unable to induce G2/M arrest or apoptosis ( Figure 4f and Table 1 ). This result was extended to three ccRCC cell lines using adenovirus-mediated expression of TRC8 CAIC (Figure 4g ). Despite similar expression levels, this RING mutation was unable to inhibit growth of ccRCCs while wild-type TRC8 was highly effective. These results demonstrate that the known biological effects of TRC8 require the Ub ligase activity of its RING domain.
TRC8 activates ATM and Chk2 kinases G2/M arrest suggested that upstream checkpoint activators might be influenced by TRC8. Western blot 
RING-dependent tumor suppression by TRC8
A Brauweiler et al analysis was used to examine the activation state of Chk2 and ATM kinases in response to TRC8 induction. Wild-type but not RING mutant TRC8 resulted in phosphorylation of Chk2 on Thr 68 (Figure 4h ), a site essential for subsequent autophosphorylation in the activation loop. The Thr 68 site is phosphorylated by activated ATM/ATR kinases, and we found that TRC8 induction resulted in Ser1981 phosphorylation of ATM (Figure 4g , bottom panels). Here also, the RING mutant TRC8
CAIC did not alter phosphor-ATM levels. These modifications are consistent with the G2/M arrest observed in Figures 2c and 4f. TRC8 inhibits tumor formation in a nude mouse model Xenograft studies were conducted to determine if TRC8 could suppress tumorigenicity of 293FI cells. Stable transfectants carrying inducible TRC8 wt or TRC8 CAIC were inoculated subcutaneously into nu/nu mice. Half of each animal group received dox continuously in the drinking water starting 1 day before tumor cell injection. Dox-induced TRC8 wt -expressing cells did not form any tumors, but expression of the TRC8 CAIC RING mutation permitted robust tumor formation (Figure 5a ). Measurement of tumor diameters (at day 34 postinoculation) revealed similar growth rates for tumors derived from uninduced TRC8 wt -and TRC8 CAIC -transfected cells and for tumors induced to express the TRC8 CAIC mutation (Figure 5b ). These studies demonstrate that wild-type TRC8 is a potent tumor suppressor when expressed in HEK293 cells and this effect is dependent upon a functional RING domain.
Ectopic SREBP can partly restore growth to TRC8-inhibited cells We recently discovered that TRC8 downregulates expression of SREBP target genes in HEK293 cells In vitro ubiquitylation reactions (see Supplementary Methods) were carried out using GST fusion proteins containing the indicated wild-type or mutant RING domains of TRC8. The AO7 RING domain fused to GST served as a positive control (lane 7) (Lorick et al., 1999) . Radiolabelled Ub was incorporated into high molecular weight products in a reaction containing murine E1, Ube2d2, 32 P-Ub, ATP and an ATP regeneration system. Labelled products were detected by SDS-PAGE and phosphorimaging. Background bands observed with GST alone (lane 1) are tentatively identified along the right side. (c) Purified GST fusion proteins were semi-quantified by Coomassie Blue staining and comparison to a bovine serum albumin standard.
A Brauweiler et al (Lee et al., submitted). (Figure 6a ). TRC8 expression reduced cell number to about 35% of uninduced control cells (Po0.001). Although nSREBP1 had no effect on uninduced cells, it doubled cell numbers for TRC8-inhibited cells, restoring growth to about 70% of controls (Po0.01). Despite this increase, expression of constitutively active nSREBP did not fully restore growth, suggesting that 
A Brauweiler et al additional mechanisms are contributing to TRC8-mediated inhibition. Co-transfection of pSYNSRE-luc (Figure 5b, top panel) , a reporter plasmid sensitive to SREBP activation, verified that nSREBP protein (bottom panel) was active.
Discussion
Our results show that TRC8 inhibits proliferation in mammalian cells through mechanisms involving G2/M arrest and cell death. Ectopic TRC8 expression in RCC lines induced cell death (Figure 1) , whereas in HEK293 cells, a combination of G2/M arrest and cell death was observed (Figure 2 ). DNA synthesis, as measured by BrdU incorporation, was also inhibited. Cell cycle checkpoint kinases ATM and Chk2 were activated by TRC8 expression (Figure 4g ), consistent with G2/M arrest (Figures 2c and 4f ). ATM is activated by radiation-induced DNA damage or by reactive oxygen species (Falck et al., 2001; Ito et al., 2004) . ATM kinase phosphorylates Chk2 and activates p53 and BRCA1, inhibits CDC25A/C phosphatases and inhibits cell cycle progression (Matsuoka et al., 1998; Falck et al., 2001) . How TRC8 induces ATM phosphorylation is unknown, but ATM inactivation leads to increased reactive oxygen species (Ito et al., 2004) , suggesting a connection to the VHL/HIF system (Kaelin, 2005) and/or to the hypoxic activation of SREBPs (Hughes et al., 2005) . The lack of proliferative alterations from overexpression of the TRC8-related RING protein, gp78 (Figure 4) , supports the conclusion that TRC8 growth effects are specific.
Subcutaneous tumor formation by HEK293 cells was completely blocked by induction of TRC8, while uninduced cells formed tumors efficiently. These results support a tumor suppressor role for TRC8 in mammalian cells (Figure 5) , consistent with our previous data in Drosophila where dTrc8 inhibited wing and eye imaginal disc development (Gemmill et al., 2002 (Gemmill et al., , 2005 . As the current results have been obtained only in kidneyderived cell lines, we cannot exclude the possibility that TRC8 has cell-type-specific effects not observed here.
The C-terminus of TRC8 is able to catalyse ubiquitylation reactions in vitro in keeping with the presence of a highly conserved RING-H2 domain (Lorick et al., 1999) (Figure 3 ). Although it is likely that TRC8 generates K48-linked poly-Ub leading to proteasomemediated degradation, this has not yet been established. It is also possible that different E2s and/or substrates cause TRC8 to generate alternative linkages (e.g., K63) with alternative fates (Ciechanover, 2006) , such as protein transport, processing or activation as in the nuclear factor-kB pathway.
As with other RING proteins, mutation of the Zn 2 þ -coordinating Cys and His residues eliminates ubiquitylation activity of TRC8 (Lorick et al., 1999; Zheng et al., showed significantly increased apoptotic and G2/M populations and significantly decreased G1/S (Po0.0001, one-way analysis of variance) compared to uninduced cells. Thirty-six hours induction with 100 ng/ml doxycycline.
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. Importantly, all the mutations that lost this activity also lost the biological effects (Figure 4d-g ). Moreover, the TRC8 CAIC RING mutation lost the ability to inhibit tumor formation ( Figure 5 ). These results support the hypothesis that the ubiquitylation activity of the RING domain is essential for TRC8 function.
The LRK mutation, which affects three non-Zn 2 þ -coordinating residues adjacent to the third Zn-binding half-site (Figure 3a) , eliminated ubiquitylation activity while the SAR mutation retained nearly 30% of wildtype activity. These sites were chosen for mutagenesis on the basis of crystallographic and nuclear magnetic resonance (NMR) structural data suggesting their importance for interactions with E2 Ub-conjugating enzymes (Zheng et al., 2000; Katoh et al., 2003) . Our preliminary data suggest that the TRC8 RING domain can utilize a number of E2 enzymes for ubiquitylation, at least in vitro (K. Lorick, unpublished observations). As the ubiquitylation assays in Figure 3 tested only Ube2d2 (UbcH5b), it is possible that the LRK and SAR mutations retain the capability to utilize other E2's. This may explain why SAR, with strongly reduced Ube2d2-dependent activity, nevertheless retained nearly wildtype G2/M and apoptotic effects.
We recently discovered that TRC8 induction reduced the expression of SREBP target genes (Lee et al., submitted, and Table 2 ). In mammalian cells, cholesterol and lipid homeostasis is regulated by an ER complex including Insulin-Induced Gene (INSIG), SREBP Cleavage Activating Protein (SCAP) and SREBPs (Goldstein et al., 2006) . Sterol starvation induces cholesterol and fatty acid biosynthetic enzymes by activating the latent transcription factor activity of the SREBPs through a unique mechanism of cholesterolsensitive transport and intra-membrane cleavage in the Golgi (Horton et al., 2002 (Horton et al., , 2003 Goldstein et al., 2006) . This process depends upon pre-SREBP binding of SCAP along with a cholesterol-mediated interaction with INSIG. Interestingly, ccRCCs are characterized by lipid inclusions composed primarily of newly synthesized cholesterol esters and other neutral lipids (Clayman et al., 1986; Gebhard et al., 1987) , suggesting that this lipid homeostasis pathway is deregulated in the most common type of kidney tumor. Moreover, the mevalonate pathway initiated by HMGCR is necessary for isoprenoid biosynthesis and prenylation of small GTPase proteins such as Ras and Rap. Thus, inhibition of the SREBP pathway by TRC8 could have important consequences for proliferation.
We thus tested the ability of activated, nSREBP1a to restore growth to TRC8-inhibited cells (Figure 6 ). Transfection of nSREBP1a was able to restore some growth to HEK293 cells. These observations suggest that TRC8 Ub ligase and tumor suppressor activities may form one connection between growth control and lipid homeostasis. However, growth restoration was not complete, suggesting that while SREBP destabilization has an important role, additional mechanisms are likely important for TRC8-mediated inhibitory effects. Surprisingly, the SREBP pathway has recently been identified as the major oxygen-sensing mechanism in fission yeast (Hughes et al., 2005; Todd et al., 2006) . In preliminary experiments, we found that severe hypoxia induced some SREBP target genes and that ectopic TRC8 could block this (H Drabkin, unpublished observations). These observations support a connection between SREBP-mediated lipid biosynthesis and hypoxia responses in mammalian cells. The major mechanism of renal cancer development involves mutation of VHL and deregulation of HIF-a (Kaelin, 2004) . Thus, we suggest that hypoxia may deregulate fatty acid and sterol biosynthesis and that by modulating the SREBP Figure 6 Activated SREBP partially restores growth to TRC8 inhibited cells. (a) HEK293FI cells containing TRC8 wt were transfected, in triplicate, with vector alone (pCMV7) or with pCMV7-nSREBP-1 expressing the nuclear, activated form of SREBP-1a (nSREBP). Cells were simultaneously induced to express TRC8 with dox treatment (1 mg/ml). Viable cell counts were performed 48 h post-transfection/induction. Differences in growth between uninduced and induced cells (untransfected with nSREBP1a) were statistically significant (**Po0.001) as were differences in growth between uninduced and induced cells transfected with nSREBP1a (*Po0.01, one-way analysis of variance). Data are representative of four repetitions. (b) Cultures of 293FI cells containing TRC8 wt or TRC8 CAIC were co-transfected with the pSYNSRE-luc reporter construct with or without pCMV7-nSREBP1. Induction of luciferase activity verified the nSREBP1a constructs. Protein expression of nSREBP1a was verified by Western blot; asterisk indicates a background band indicative of even loading.
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Materials and methods
Expression constructs TRC8-HA in GFPC1 (Gemmill et al., 2002) was transferred to the pAdTrack-CMV vector using KpnI. The CAIC mutation was created in full-length TRC8 (without the HA-tag) by sitedirected mutagenesis (QuikChange kit, Stratagene, La Jolla, CA, USA). Sequence confirmed pAdTrack clones were electroporated into pAdEasy-containing BJ5183 cells, selected for recombination and transfected into HEK293 cells for virus production. TRC8-HA insert was transferred to pcDNA5/ FRT/TO using KpnI and verified by sequence analysis. Sitedirected mutagenesis also generated all RING mutations in both full-length TRC8-HA and in GST-TRC8 513À664 , a Cterminal fusion described previously along with the GST-AO7 RING fusion (Lorick et al., 1999) . Full-length gp78 insert was transferred to pcDNA5/FRT/TO from pCIneo-gp78 (Fang et al., 2001) using NotI.
Generation of TET-on FlpIn TRex cell lines HEK293FI lines carrying TET-inducible constructs were generated by co-transfection of pcDNA5/FRT/TO with pOG44 encoding Flp-recombinase (1:10 pcDNA5:pOG44) using FuGENE6 (Roche Diagnostics, Indianapolis, IN, USA). After 2 days, recombinant cells were selected in 50 mg/ ml hygromycin B (Invitrogen, Carlsbad, CA, USA) and 5 mg/ ml blasticidin. Dox-inducible expression of HA-tagged proteins was verified for each construct by Western blot.
Flow cytometric analysis and BrdU labelling
Harvested cells were washed and resuspended in propidium iodide with 0.3% saponin. Cell cycle analysis was carried out on an FC500 flow cytometer (Beckman Coulter, Fullerton, CA, USA). Results were analysed using the CXP software package. For BrdU incorporation, cells were incubated with BrdU (Sigma-Aldrich, St Louis, MO, USA), washed, fixed, permeabilized and stained with anti-BrdU antibody (BD Biosciences, San Jose, CA, USA). Secondary was Alexa 488-conjugated F(ab 0 )2 fragments of goat anti-mouse immunoglobulin G.
Tumorigenicity assay
Four groups of 12 mice each were inoculated subcutaneously with 5 Â 10 6 293FI cells containing either dox-inducible TRC8 wt or TRC8 CAIC . Two groups (one group per line) were pretreated for 24 h with 1 mg/ml dox in water containing 1% sucrose, which was changed every 2-3 days. Examinations for tumor take were performed three times a week and tumor diameters were measured at 22 and 34 days.
Supplemental methods
Detailed descriptions of antibodies, real-time PCR primers (Ohira et al., 2003) , in vitro ubiquitylation reactions (Lorick et al., 1999) and cell culturing are provided in Supplemental Methods.
